MedTrace Logo

Study of Patient Use and Perception of the Travatan Dosing Aid

NCT00626067 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2016-11-10

No results posted yet for this study

Summary

The primary objective of this study is to determine the opinions of patients who are given the Travatan Compliance Monitoring Dispenser to use to dispense their Travatan glaucoma drops.

Conditions

Interventions

DEVICE

Fully functional monitoring device

Pt received fully functional monitoring dispenser for use with their Travatan eye drops

DEVICE

Partially functional monitoring device

Patient received a particually functional Travatan Compliance Monitoring Dispenser

DEVICE

Non-functional monitoring device

Patient received a non functioning Travatan Compliance Monitoring Dispenser

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Wills Eye

    lead OTHER

Principal Investigators

  • Jonathan S. Myers, MD · Wills Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-02-28
Completion
2007-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00626067 on ClinicalTrials.gov